Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

The study did not provide details on the proportion of patients with therapy-related or secondary acute myeloid leukaemia, and on those with a poor or intermediate-risk karyotype. Complete remission ...

Red blood cells are the most abundant cells in the body. It has long been known that when red blood cells break down or ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...